Cerus Corporation
General ticker "CERS" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $280.1M (TTM average)
Cerus Corporation follows the US Stock Market performance with the rate: 32.0%.
Estimated limits based on current volatility of 3.1%: low 1.91$, high 2.03$
Factors to consider:
- Total employees count: 281 (-2.4%) as of 2024
- US accounted for 61.6% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Product commercialization failure, Corruption risks in emerging markets, Sanctions and distributor risks, Geopolitical risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.27$, 2.63$]
- 2025-12-31 to 2026-12-31 estimated range: [1.36$, 2.79$]
Financial Metrics affecting the CERS estimates:
- Positive: with PPE of -14.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 18.93 < Shareholder equity ratio, % of 27.94 <= 41.86
- Positive: -4.48 < Investing cash flow per share per price, % of -2.79
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Positive: Interest expense per share per price, % of 3.05 <= 3.41
Short-term CERS quotes
Long-term CERS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $162.05MM | $156.37MM | $180.27MM |
| Operating Expenses | $196.13MM | $186.42MM | $194.50MM |
| Operating Income | $-34.08MM | $-30.05MM | $-14.22MM |
| Non-Operating Income | $-8.26MM | $-7.27MM | $-6.53MM |
| Interest Expense | $5.83MM | $8.39MM | $8.88MM |
| R&D Expense | $64.11MM | $67.64MM | $58.91MM |
| Income(Loss) | $-42.34MM | $-37.32MM | $-20.76MM |
| Taxes | $0.49MM | $0.33MM | $0.20MM |
| Profit(Loss)* | $-42.78MM | $-37.49MM | $-20.92MM |
| Stockholders Equity | $67.61MM | $52.65MM | $56.15MM |
| Inventory | $29.00MM | $39.87MM | $38.15MM |
| Assets | $218.09MM | $197.75MM | $200.92MM |
| Operating Cash Flow | $-25.61MM | $-43.17MM | $11.36MM |
| Capital expenditure | $2.00MM | $4.60MM | $2.84MM |
| Investing Cash Flow | $8.46MM | $8.62MM | $-8.13MM |
| Financing Cash Flow | $4.19MM | $10.67MM | $4.96MM |
| Earnings Per Share** | $-0.24 | $-0.21 | $-0.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.